Opportunistic infections in patients with pulmonary alveolar proteinosis

被引:90
|
作者
Punatar, Ankit D. [2 ]
Kusne, Shimon [1 ]
Blair, Janis E. [1 ]
Seville, M. Teresa [1 ]
Vikram, Holenarasipur R. [1 ]
机构
[1] Mayo Clin, Div Infect Dis, Phoenix, AZ 85054 USA
[2] Mayo Clin Phoenix, Dept Internal Med, Phoenix, AZ USA
关键词
Pulmonary alveolar proteinosis; Nocardia; Mycobacteria; Fungal; Infection; COLONY-STIMULATING FACTOR; AVIUM-INTRACELLULARE INFECTION; BRONCHOPULMONARY LAVAGE; NOCARDIA-ASTEROIDES; ASSOCIATION; TUBERCULOSIS; ABSCESS; SULFAMETHOXAZOLE; CRYPTOCOCCOSIS; HISTOPLASMOSIS;
D O I
10.1016/j.jinf.2012.03.020
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To describe the demographics, clinical manifestations, treatment, and outcomes of patients with pulmonary alveolar proteinosis (PAP) who developed an opportunistic infection with Nocardia spp., mycobacteria or fungal pathogens. Methods: A case of PAP and Nocardia spp. brain abscess is described. A comprehensive review of the English-language literature was conducted to identify all reported cases of PAP and opportunistic infections between 1950 and July, 2010. Results: Seventy five cases were reviewed. Thirty two patients (43%) had nocardial infection, 28 (37%) mycobacterial infection, and 15 (20%) fungal infection. Thirty nine patients (65%) were male. Seventeen patients (23%) were immunosuppressed. Twenty patients (27%) were active smokers. PAP was the initial diagnosis in 19 patients (33%), while infection presented first in 23 patients (40%); 16 patients (27%) had a concurrent diagnosis of PAP and infection. The average interval between PAP diagnosis and an opportunistic infection was 16 months. Lungs were the most common site of infection; extra-pulmonary infection was present in 27 patients (32%). Thirty nine patients (57%) survived through the follow-up period, while 31 died. Conclusions: Opportunistic infections can either precede or follow a diagnosis of PAP. PAP should be considered in apparently immunocompetent patients who present with an opportunistic infection and diffuse alveolar infiltrates. (C) 2012 Published by Elsevier Ltd on behalf of The British Infection Association.
引用
收藏
页码:173 / 179
页数:7
相关论文
共 50 条
  • [21] Pulmonary alveolar proteinosis
    McElvaney, O. J.
    Horan, D.
    Franciosi, A. N.
    Gunaratnam, C.
    McElvaney, N. G.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2018, 111 (03) : 185 - 186
  • [22] PULMONARY ALVEOLAR PROTEINOSIS
    不详
    SCIENCE, 1958, 127 (3307) : 1164 - 1165
  • [23] PULMONARY ALVEOLAR PROTEINOSIS
    PHILLIPS, J
    SIMON, L
    ROBIN, ED
    LASURE, R
    THEODORE, J
    LYNNEDAVIES, P
    LEWISTON, NJ
    WESTERN JOURNAL OF MEDICINE, 1976, 124 (01): : 29 - 35
  • [24] PULMONARY ALVEOLAR PROTEINOSIS
    FARCA, A
    MAHER, G
    MILLER, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 224 (09): : 1283 - 1285
  • [25] Pulmonary alveolar proteinosis
    Briens, E
    Delaval, P
    Mairesse, MP
    Valeyre, D
    Wallaert, B
    Lazor, R
    Cordier, JF
    REVUE DES MALADIES RESPIRATOIRES, 2002, 19 (02) : 166 - 182
  • [26] PULMONARY ALVEOLAR PROTEINOSIS
    LYNTON, M
    BORRELLI, FJ
    NEW YORK STATE JOURNAL OF MEDICINE, 1967, 67 (15) : 2139 - &
  • [27] Pulmonary alveolar proteinosis
    Shattuck, Trisha M.
    Bean, Sarah M.
    DIAGNOSTIC CYTOPATHOLOGY, 2013, 41 (07) : 620 - 622
  • [28] Pulmonary Alveolar Proteinosis
    Khan, Ajmal
    Agarwal, Ritesh
    RESPIRATORY CARE, 2011, 56 (07) : 1016 - 1028
  • [29] Pulmonary alveolar proteinosis
    Jouneau, Stephane
    Menard, Cedric
    Lederlin, Mathieu
    RESPIROLOGY, 2020, 25 (08) : 816 - 826
  • [30] Pulmonary alveolar proteinosis
    Borie, R.
    Danel, C.
    Debray, M-P.
    Taille, C.
    Dombret, M-C.
    Aubier, M.
    Epaude, R.
    Crestani, B.
    EUROPEAN RESPIRATORY REVIEW, 2011, 20 (120): : 98 - 107